Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Medicine
Published in: BMC Medicine 1/2009

Open Access 01-12-2009 | Commentary

Preventing contrast-induced nephropathy: problems, challenges and future directions

Author: Richard Solomon

Published in: BMC Medicine | Issue 1/2009

Login to get access

Abstract

Contrast-induced nephropathy is an injury to the kidney occurring as a result of exposure to intravascular contrast media. It results in both short- and long-term adverse events including mortality. Since treatment of the injury after it has occurred is ineffective, efforts to prevent the injury are the focus of investigators and clinicians alike. In this commentary, the pathogenesis and clinical relevance of contrast-induced nephropathy are reviewed. Prophylactic strategies are discussed with a focus on the use of meta-analysis of small single-center trials.
Literature
1.
Gruberg L, Mintz GS, Mehran R, Dangas G, Lansky AJ, Kent KM, Pichard AD, Satler LF, Leon MB: The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000, 36: 1542-1548.CrossRefPubMed
2.
McCullough PA, Sandberg KA: Epidemiology of contrast-induced nephropathy. Rev Cardiovasc Med. 2003, S3-S9. Suppl 5
3.
Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR: Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002, 105: 2259-2264.CrossRefPubMed
4.
Meier P, Ko DT, Tamura A, Tamhane U, Gurm HS: Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis. BMC Medicine. 2009, 7: 23.CrossRefPubMedPubMedCentral
5.
Romano G, Briguori C, Quintavalle C, Zanca C, Rivera NV, Colombo A, Candorelli G: Contrast agents and renal cell apoptosis. Eur Heart J. 2008, 29: 2569-2576.CrossRefPubMed
6.
Bakris G, Lass N, Gaber AO, Jones JD, Burnett JC: Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol. 1990, 258: F115-F120.PubMed
7.
Persson BP, Hansell P, Liss P: Pathophysiology of contrast medium-induced nephropathy. Kidney Int. 2005, 68: 14-22.CrossRefPubMed
8.
Han W, Waikar SS, Johnson A, Betensky RA, Dent CL, Devarajan P, Bonventre JV: Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 2008, 73: 863-869.CrossRefPubMed
9.
10.
Bachorzewsha-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Pawlak K, Mysliwiec M, Lawnicki S, Szmitkowski M, Dobrzycki S: Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values?. Kidney Blood Press Res. 2007, 30: 408-415.CrossRef
11.
Devarajan P: Serum NGAL and cystatin C as predictive biomarkers for acute kidney injury [abstract]. J Am Soc Nephrol. 2006, 17: 404A.CrossRef
12.
Herget-Rosenthal S, Marggraf G, Husing J, Goring F, Pietruck F, Janssen O, Philipp T, Kribben A: Early detection of acute renal failure by serum cystatin C. Kidney Int. 2004, 66: 1115-1122.CrossRefPubMed
13.
Kelly A, Dwamena B, Cronin P, Bernstein SJ, Carlos RC: Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med. 2008, 148: 284-294.CrossRefPubMed
14.
Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA, Rittase RA, Norton HJ, Kennedy TP: Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004, 291: 2328-2334.CrossRefPubMed
15.
Spargias IK, Alexopoulos E, Kyrzopoulos S, Iokovis P, Greenwood DC, Manginas A, Voudris V, Pavlides G, Buller CE, Kremastinos D, Cokkinos DV: Ascorbic acid prevents contrast-mediated nephropathy in patient with renal dysfunction undergoing coronary angiography or intervention. Circulation. 2004, 110: 2837-2842.CrossRefPubMed
16.
Tepel M, Giet Van Der M, Schwarzfeld C, Laufer U, Liermann D, Zidek W: Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000, 343: 180-184.CrossRefPubMed
17.
Gonzales D, Norsworthy KJ, Kern SJ, Banks S, Sieving PC, Star RA, Natanson C, Danner RL: A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity. BMC Medicine. 2007, 5: 32-45.CrossRefPubMedPubMedCentral
18.
Halliwell B, Gutteridge JMC: Role of free radicals and catalytic metal ions in human diseases: an overview. Methods Enzymol. 1990, 186: 1-85.CrossRefPubMed
19.
Pakfetrat M, Nikoo MH, Malehmakan L, Tabandeh M, Roozbeh J, Nasab MH, Ostovan MA, Salari S, Kafi M, Vaziri NM, Adl F, Hosseini M, Khajehdehi P: A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: a randomized, double-blind trial. Int Urol Nephrol. 2009.
20.
Solomon R: REMEDIAL: a role for sodium bicarbonate in the prevention of contrast-induced nephropathy. Nat Clin Pract Cardiovasc Med. 2007, 4: 474-475.CrossRefPubMed
21.
Navaneethan S, Singh S, Appasamy S, Wing RE, Sehgal AR: Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Am J Kidney Dis. 2009, 53: 617-627.CrossRefPubMed
22.
Solomon R, Briguori C, Bettmann M: Selection of contrast media. Kidney Int. 2006, S39-S45. Suppl 100
23.
Marenzi G, Lauri G, Campodonico J, Marana I, Assanelli E, De Metrio M, Veglia F, Fabbiocchi F, Montorsi P, Bartorelli A: Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Am J Med. 2006, 119: 155-162.CrossRefPubMed
24.
Solomon R, Mehran R, Natarajan MK, Soucet S, Katholi RE, Staniloae CS, Sharma SK, Labinaz M, Gelormini JL, Barrett BJ: Contrast-induced nephropathy and long-term adverse events: cause and effect?. Clin J Am Soc Nephrol. 2009.
25.
Miner SE, Szavik V, Nguyen-Ho P, Richardson R, Mitchell J, Atchison D, Seidelin P, Daly P, Ross J, McLaughlin PR, Ing D, Lewycky P, Barolet A, Schwartz L: N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up. Am Heart J. 2004, 148: 690-695.CrossRefPubMed
26.
Mueller C, Buerkle G, Buettner H, Petersen J, Perruchoud AP, Eriksson U, Marsch S, Roskamm H: Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angiography. Arch Int Med. 2002, 162: 329-336.CrossRef
27.
Stone GW, McCullough P, Tumlin J, Lepor NE, Madyoon H, Murray P, Wang A, Chu AA, Schaer GL, Stevens M, Wilensky RL, O'Neill WW: Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA. 2003, 290: 2284-2291.CrossRefPubMed
Metadata
Title
Preventing contrast-induced nephropathy: problems, challenges and future directions
Author
Richard Solomon
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2009
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/1741-7015-7-24

Other articles of this Issue 1/2009

BMC Medicine 1/2009 Go to the issue

Research article

Patient to patient transmission of hepatitis B virus: a systematic review of reports on outbreaks between 1992 and 2007

Research article

STAT1-dependent expression of energy metabolic pathways links tumour growth and radioresistance to the Warburg effect

Research article

Malaria paediatric hospitalization between 1999 and 2008 across Kenya

Research article

Accumulation of neutral lipids in peripheral blood mononuclear cells as a distinctive trait of Alzheimer patients and asymptomatic subjects at risk of disease

Research article

Development of the probability of return of spontaneous circulation in intervals without chest compressions during out-of-hospital cardiac arrest: an observational study

Minireview

Migraine pathogenesis and state of pharmacological treatment options